Kidney Cancer Journal | Volume 9, June 2025
Special Issue: Updates in Kidney Tumor Classification, Morphology, and Molecular Alterations...
Read More
Select Page
by Kidney Cancer Journal | Jul 2025
Special Issue: Updates in Kidney Tumor Classification, Morphology, and Molecular Alterations...
Read Moreby Kidney Cancer Journal | Jun 2025
Surgical approaches following durable responses to immunotherapy​ An ongoing question in the...
Read Moreby Mohamad E. Allaf, MD | Oct 2024
Mohammed E. Allaf, MD, presents a comprehensive overview of managing small renal tumors, focusing on a guidelines-based approach that integrates the latest evidence and expert consensus in the evolving landscape of renal tumor management.
In this 20-minute presentation, Dr. Allaf outlines the current guidelines for evaluating small renal masses. He highlights the critical factors influencing management choices, including gender, tumor size, location, patient comorbidities, age, and family history.
In discussing treatment options, Dr. Allaf examines active surveillance, radical or partial nephrectomy, and ablative therapies and the indications for each approach. He also touches on future directions in treatment and imaging while emphasizing the benefits of the current guidelines.
Read Moreby Kidney Cancer Journal | Jan 2024
Efficacy, Effectiveness, and Safety of Interventions for Von Hippel-Lindau Associated Renal Cell...
Read Moreby Jeremy Slawin, MD, MBA | Dec 2023
Jeremy Slawin, MD, addresses competing risks in managing small renal masses (SRMs), balancing treatment versus natural progression of disease.
Read Moreby Benjamin K. Canales, MD, MPH | Jun 2023
Benjamin K. Canales, MD, MPH, discusses Percutaneous Nephrostolithotomy (PCNL), how to mitigate the risk of SIRS and sepsis associated with the operation, and various techniques used to perform the PCNL. In this presentation, Dr. Canales discusses, the importance of prophylactic antibiotics in infection prevention and mitigation, the history of PCNL, the risks and benefits of various sites for obtaining renal access, and the pros and cons of the known techniques for performing PCNL.
Read Moreby Kidney Cancer Journal | May 2023
Adjuvant Therapy in Renal Cell Carcinoma: Are We Ready for Prime Time? Abstract The standard of...
Read Moreby Kidney Cancer Journal | Dec 2022
Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor...
Read Moreby Kidney Cancer Journal | Sep 2022
In Memoriam: Nicholas J. Vogelzang MD1 Abstract Dr. Nick Vogelzang passed away on September 20th,...
Read Moreby Kidney Cancer Journal | Jun 2022
Hereditary Renal Cell Carcinoma Abstract BACKGROUND:Hereditary renal cell carcinoma (RCC) is a...
Read Moreby Kidney Cancer Journal | Mar 2022
In Memoriam: Chris Wood Abstract It is with great sadness that we heard of the loss of Chris Wood...
Read Moreby Kidney Cancer Journal | Dec 2021
Sarcomatoid Renal Cell Carcinoma: The Present and Future of Treatment Paradigms Abstract...
Read More